Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide

Journal of Pharmacy and Pharmacology

Volumn 69, Issue 11, 2017, Pages 1477-1484

  Svagan, Anna Justina ^a   Müllertz, Anette ^b   Löbmann, Korbinian ^b  

^a School of Chemical Science and Engineering   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cellular solid material; cellulose nanofibres; foam; furosemide; sustained release

Indexed keywords

CELLULOSE NANOFIBER; FUROSEMID RATIOPHARM; FUROSEMIDE; NANOFIBER; SODIUM; UNCLASSIFIED DRUG; CELLULOSE; EXCIPIENT;

ARTICLE; CONTROLLED STUDY; CRYSTAL; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; FOAM; FOAMING; PARTICLE SIZE; PHYSICAL CHEMISTRY; SOLID STATE; SURFACE PROPERTY; SUSPENSION; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE PREPARATION; TABLET; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; MEDICINAL CHEMISTRY; PROCEDURES; SOLUBILITY;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; EXCIPIENTS; FUROSEMIDE; NANOFIBERS; SOLUBILITY;

EID: 85030626847     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12793     Document Type: Article

References (32)

1. Williams RO et al. eds. Formulating Poorly Water Soluble Drugs, AAPS Advances in Pharmaceutical Sciences Series 3. New York, NY: AAPS Press, Springer, 2012.
2. Hörter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract1. Adv Drug Deliver Rev 2001; 46: 75–87.
3. Matsuda Y, Tatsumi E. Physicochemical characterization of furosemide modifications. Int J Pharm 1990; 60: 11–26.
4. Nielsen LH et al. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Eur J Pharm Biopharm 2013; 85: 942–951.
5. Chungi VS et al. Gastrointestinal sites of furosemide absorption in rats. Int J Pharm 1979; 4: 27–38.
6. Klausner EA et al. Expandable gastroretentive dosage forms. J Control Release 2003; 90: 143–162.
7. Klausner EA et al. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 2002; 19: 1516–1523.
8. Waterman KC. A critical review of gastric retentive controlled drug delivery. Pharm Dev Technol 2007; 12: 1–10.
9. Hoffman A et al. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int J Pharm 2004; 277: 141–153.
10. Svagan AJ et al. Solid cellulose nanofiber based foams – towards facile design of sustained drug delivery systems. J Control Release 2016; 244 (Part A): 74–82.
11. Löbmann K et al. Cellulose nanopaper and nanofoam for patient-tailored drug delivery. Adv Mater Interfaces 2017; 4: 1600655.
12. Henriksson M et al. Cellulose nanopaper structures of high toughness. Biomacromolecules 2008; 9: 1579–1585.
13. Saito T et al. An ultrastrong nanofibrillar biomaterial: the strength of single cellulose nanofibrils revealed via sonication-induced fragmentation. Biomacromolecules 2013; 14: 248–253.
14. Kolakovic R et al. Spray-dried nanofibrillar cellulose microparticles for sustained drug release. Int J Pharm 2012; 430: 47–55.
15. Kolakovic R et al. Evaluation of drug interactions with nanofibrillar cellulose. Eur J Pharm Biopharm 2013; 85: 1238–1244.
16. Djuric T et al. Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis. J Clin Lab Anal 2010; 24: 246–251.
17. Kolakovic et al. Nanofibrillar cellulose films for controlled drug delivery. Eur J Pharm Biopharm 2012; 82: 308–315.
18. Lavoine N et al. Modeling of caffeine release from a cellulosic substrate coated with microfibrillated cellulose. J Control Release 2015; 213: E83–E84.
19. Valo H et al. Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels. Eur J Pharm Sci 2013; 50: 69–77.
20. Valo H et al. Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices-enhanced stability and release. J Control Release 2011; 156: 390–397.
21. Kalashnikova I et al. Modulation of cellulose nanocrystals amphiphilic properties to stabilize oil/water interface. Biomacromolecules 2012; 13: 267–275.
22. Cervin NT et al. Mechanisms behind the stabilizing action of cellulose nanofibrils in wet-stable cellulose foams. Biomacromolecules 2015; 16: 822–831.
23. Svagan AJ et al. Liquid-core nanocellulose-shell capsules with tunable oxygen permeability. Carbohydr Polym 2016; 136: 292–299.
24. Hasani M et al. Cationic surface functionalization of cellulose nanocrystals. Soft Matter 2008; 4: 2238–2244.
25. Cervin NT et al. Lightweight and strong cellulose materials made from aqueous foams stabilized by nanofibrillated cellulose. Biomacromolecules 2013; 14: 503–511.
26. Stocco A et al. Aqueous foams stabilized solely by particles. Soft Matter 2011; 7: 1260–1267.
27. Stocco A et al. Particle-stabilised foams: an interfacial study. Soft Matter 2009; 5: 2215–2222.
28. Pickering SU. Emulsions. J Chem Soc 1907; 91: 2001.
29. Mota FL et al. Temperature and solvent effects in the solubility of some pharmaceutical compounds: measurements and modeling. Eur J Pharm Sci 2009; 37: 499–507.
30. Patel RP et al. Physicochemical characterization and dissolution study of solid dispersions of furosemide with polyethylene glycol 6000 and polyvinyl pyrrolidone K30. Dissolut Technol 2008; 15: 17–25.
31. Rao Khandavilli UB et al. High solubility crystalline hydrates of Na and K furosemide salts. Cryst Eng Comm 2014; 16: 4842–4852.
32. Schönbichler SA et al. Comparison of NIR chemical imaging with conventional NIR, Raman and ATR-IR spectroscopy for quantification of furosemide crystal polymorphs in ternary powder mixtures. Eur J Pharm Biopharm 2013; 84: 616–625.